{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:28:12Z","timestamp":1789997292469,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-024-01851-6","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T08:25:30Z","timestamp":1720686330000},"page":"1352-1368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Whole-body MRI in oncology: acquisition protocols, current guidelines, and beyond"],"prefix":"10.1007","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-4760","authenticated-orcid":false,"given":"Fabio","family":"Zugni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1061-365X","authenticated-orcid":false,"given":"Leonardo","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-0099","authenticated-orcid":false,"given":"Doenja M. J.","family":"Lambregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-3864","authenticated-orcid":false,"given":"Roberta","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5085-1095","authenticated-orcid":false,"given":"Paul E.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6601-3221","authenticated-orcid":false,"given":"Vincenza","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-3256","authenticated-orcid":false,"given":"Annarita","family":"Pecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-8322","authenticated-orcid":false,"given":"Giuseppe","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-6029","authenticated-orcid":false,"given":"Federica","family":"De Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-3442","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Cardobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-652X","authenticated-orcid":false,"given":"Andrea","family":"Giovagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-3643","authenticated-orcid":false,"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"6","key":"1851_CR1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2214\/ajr.169.6.9393186","volume":"169","author":"S Eustace","year":"1997","unstructured":"Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole-body turbo STIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655\u20131661. https:\/\/doi.org\/10.2214\/ajr.169.6.9393186","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1851_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/(sici)1522-2586(200004)11:4<343:aid-jmri1>3.0.co;2-p","volume":"11","author":"R Walker","year":"2000","unstructured":"Walker R, Kessar P, Blanchard R, Dimasi M, Harper K, DeCarvalho V, Yucel EK, Patriquin L, Eustace S (2000) Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 11(4):343\u2013350. https:\/\/doi.org\/10.1002\/(sici)1522-2586(200004)11:4%3c343:aid-jmri1%3e3.0.co;2-p","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"1851_CR3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00330-008-0968-z","volume":"18","author":"TC Kwee","year":"2008","unstructured":"Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18(9):1937\u20131952. https:\/\/doi.org\/10.1007\/s00330-008-0968-z","journal-title":"Eur Radiol"},{"key":"1851_CR4","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2021.1164","author":"P Summers","year":"2021","unstructured":"Summers P, Saia G, Colombo A, Pricolo P, Zugni F, Alessi S, Marvaso G, Jereczek-Fossa BA, Bellomi M, Petralia G (2021) Whole-body magnetic resonance imaging: technique, guidelines and key applications. Ecancermedicalscience. https:\/\/doi.org\/10.3332\/ecancer.2021.1164","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"1851_CR5","doi-asserted-by":"publisher","first-page":"W336","DOI":"10.2214\/AJR.17.17984","volume":"209","author":"M Morone","year":"2017","unstructured":"Morone M, Bali MA, Tunariu N, Messiou C, Blackledge M, Grazioli L, Koh DM (2017) Whole-body MRI: current applications in oncology. AJR Am J Roentgenol 209(6):W336\u2013W349. https:\/\/doi.org\/10.2214\/AJR.17.17984","journal-title":"AJR Am J Roentgenol"},{"issue":"1115","key":"1851_CR6","doi-asserted-by":"publisher","first-page":"20200562","DOI":"10.1259\/bjr.20200562","volume":"93","author":"N Tunariu","year":"2020","unstructured":"Tunariu N, Blackledge M, Messiou C, Petralia G, Padhani A, Curcean S, Curcean A, Koh DM (2020) What\u2019s new for clinical whole-body MRI (WB-MRI) in the 21st century. Br J Radiol 93(1115):20200562. https:\/\/doi.org\/10.1259\/bjr.20200562","journal-title":"Br J Radiol"},{"issue":"6","key":"1851_CR7","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2.Erratum.In:LancetOncol.2019Jul;20(7):e346","volume":"20","author":"J Hillengass","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, Garc\u00eda-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S (2019) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 20(6):e302\u2013e312. https:\/\/doi.org\/10.1016\/S1470-2045(19)30309-2.Erratum.In:LancetOncol.2019Jul;20(7):e346. (PMID: 31162104)","journal-title":"Lancet Oncol"},{"issue":"3","key":"1851_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","volume":"32","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, H\u00e1jek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U (2021) EHA Guidelines Committee. ESMO guidelines committee multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):309\u2013322. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.014","journal-title":"Ann Oncol"},{"key":"1851_CR9","unstructured":"NICE guideline [NG35] Myeloma: diagnosis and management. Published: 10 February 2016 Last updated: 25 October 2018"},{"issue":"3","key":"1851_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, Lai M, Pratt G (2017) British society for haematology guidelines. Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol 178(3):380\u2013393. https:\/\/doi.org\/10.1111\/bjh.14827","journal-title":"Br J Haematol"},{"issue":"9","key":"1851_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, Tombal B, Gillessen S (2020) ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org. Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(9):1119\u20131134. https:\/\/doi.org\/10.1016\/j.annonc.2020.06.011","journal-title":"Ann Oncol"},{"issue":"17","key":"1851_CR12","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.19.02757","volume":"38","author":"EJ Trabulsi","year":"2020","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA (2020) Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol 38(17):1963\u20131996. https:\/\/doi.org\/10.1200\/JCO.19.02757","journal-title":"J Clin Oncol"},{"issue":"6","key":"1851_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/ddg.12044","volume":"11","author":"A Pflugfelder","year":"2013","unstructured":"Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, G\u00e4rtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, H\u00fcbner J, Kaatz M, Kleeberg UR, K\u00f6lbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, L\u00f6ser C, Mackensen A, Meier F, Mohr P, M\u00f6hrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderk\u00f6tter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D (2013) German society of dermatology S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma\u201d short version. J Dtsch Dermatol Ges 11(6):563\u2013602. https:\/\/doi.org\/10.1111\/ddg.12044","journal-title":"J Dtsch Dermatol Ges"},{"key":"1851_CR14","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14279","volume":"146","author":"R Dummer","year":"2016","unstructured":"Dummer R, Siano M, Hunger RE, Lindenblatt N, Braun R, Michielin O, Mihic-Probst D, von Moos R, Najafi Y, Guckenberger M, Arnold A (2016) The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma. Swiss Med Wkly 146:w14279. https:\/\/doi.org\/10.4414\/smw.2016.14279","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"1851_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ejrad.2013.11.017","volume":"83","author":"B Li","year":"2014","unstructured":"Li B, Li Q, Nie W, Liu S (2014) Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol 83(2):338\u2013344. https:\/\/doi.org\/10.1016\/j.ejrad.2013.11.017","journal-title":"Eur J Radiol"},{"issue":"11","key":"1851_CR16","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","volume":"23","author":"CP Kratz","year":"2017","unstructured":"Kratz CP, Achatz MI, Brugi\u00e8res L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23(11):e38\u2013e45. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0408. (PMID: 28572266)","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1851_CR17","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","volume":"23","author":"U Tabori","year":"2017","unstructured":"Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugi\u00e8res L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23(11):e32\u2013e37. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0574. (PMID: 28572265)","journal-title":"Clin Cancer Res"},{"issue":"12","key":"1851_CR18","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD (2017) Von hippel-lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23(12):e68\u2013e75. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0547. (PMID: 28620007)","journal-title":"Clin Cancer Res"},{"issue":"10","key":"1851_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3389\/fonc.2020.00704","volume":"8","author":"MD Blackledge","year":"2020","unstructured":"Blackledge MD, Tunariu N, Zugni F, Holbrey R, Orton MR, Ribeiro A, Hughes JC, Scurr ED, Collins DJ, Leach MO, Koh DM (2020) Noise-corrected, exponentially weighted, diffusion-weighted MRI (niceDWI) improves image signal uniformity in whole-body imaging of metastatic prostate cancer. Front Oncol 8(10):704. https:\/\/doi.org\/10.3389\/fonc.2020.00704","journal-title":"Front Oncol"},{"issue":"2","key":"1851_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/13548506.2022.2126989","volume":"28","author":"D Busacchio","year":"2023","unstructured":"Busacchio D, Mazzoni D, Mazzocco K, Pricolo P, Summers PE, Petralia G, Pravettoni G (2023) Psychological characteristics and satisfaction for the whole-body MRI in cancer screening. Psychol Health Med 28(2):548\u2013554. https:\/\/doi.org\/10.1080\/13548506.2022.2126989","journal-title":"Psychol Health Med"},{"issue":"6","key":"1851_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10865-022-00361-y","volume":"45","author":"JE Madl","year":"2022","unstructured":"Madl JE, Sturmbauer SC, Janka R, Bay S, Rohleder N (2022) Preparing patients according to their individual coping style improves patient experience of magnetic resonance imaging. J Behav Med 45(6):841\u2013854. https:\/\/doi.org\/10.1007\/s10865-022-00361-y","journal-title":"J Behav Med"},{"issue":"3","key":"1851_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1737","volume":"6","author":"K Mazzocco","year":"2023","unstructured":"Mazzocco K, Busacchio D, Summers PE, Marzorati C, Pricolo P, Petralia G, Pravettoni G (2023) Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? Cancer Rep (Hoboken) 6(3):e1737. https:\/\/doi.org\/10.1002\/cnr2.1737","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"1851_CR23","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/jan.12917","volume":"72","author":"BM Ahlander","year":"2016","unstructured":"Ahlander BM, \u00c5restedt K, Engvall J, Maret E, Ericsson E (2016) Development and validation of a questionnaire evaluating patient anxiety during magnetic resonance imaging: the magnetic resonance imaging-anxiety questionnaire (MRI-AQ). J Adv Nurs 72(6):1368\u20131380. https:\/\/doi.org\/10.1111\/jan.12917","journal-title":"J Adv Nurs"},{"issue":"1","key":"1851_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/s15327558ijbm1101_1","volume":"11","author":"LM Harris","year":"2004","unstructured":"Harris LM, Cumming SR, Menzies RG (2004) Predicting anxiety in magnetic resonance imaging scans. Int J Behav Med 11(1):1\u20137. https:\/\/doi.org\/10.1207\/s15327558ijbm1101_1","journal-title":"Int J Behav Med"},{"issue":"2","key":"1851_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jmri.21012","volume":"26","author":"I Eshed","year":"2007","unstructured":"Eshed I, Althoff CE, Hamm B, Hermann KG (2007) Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 26(2):401\u2013404. https:\/\/doi.org\/10.1002\/jmri.21012","journal-title":"J Magn Reson Imaging"},{"key":"1851_CR26","doi-asserted-by":"crossref","unstructured":"Gabr RE, Narayana PA (2016). Patient Distraction and Entertainment System for Magnetic Resonance Imaging using Visual Effects Synchronized to the Scanner Acoustic Noise.","DOI":"10.5220\/0005680503190323"},{"issue":"4","key":"1851_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/RMR.0000000000000247","volume":"29","author":"MA Oztek","year":"2020","unstructured":"Oztek MA, Brunnquell CL, Hoff MN, Boulter DJ, Mossa-Basha M, Beauchamp LH, Haynor DL, Nguyen XV (2020) Practical considerations for radiologists in implementing a patient-friendly MRI experience. Top Magn Reson Imaging 29(4):181\u2013186. https:\/\/doi.org\/10.1097\/RMR.0000000000000247","journal-title":"Top Magn Reson Imaging"},{"issue":"4","key":"1851_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/pmu0000199","volume":"27","author":"Z F\u00f6ldes","year":"2017","unstructured":"F\u00f6ldes Z, Ala-Ruona E, Burger B, Orsi G (2017) Anxiety reduction with music and tempo synchronization on magnetic resonance imaging patients. Psychomusicology Music Mind and Brain 27(4):343\u2013349","journal-title":"Psychomusicology Music Mind and Brain"},{"issue":"5","key":"1851_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/02841850600690355","volume":"47","author":"E T\u00f6rnqvist","year":"2006","unstructured":"T\u00f6rnqvist E, M\u00e5nsson A, Larsson EM, Hallstr\u00f6m I (2006) Impact of extended written information on patient anxiety and image motion artifacts during magnetic resonance imaging. Acta Radiol 47(5):474\u2013480. https:\/\/doi.org\/10.1080\/02841850600690355","journal-title":"Acta Radiol"},{"issue":"1","key":"1851_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, Lecouvet FE, Moulopoulos LA, Collins DJ, Blackledge MD, Abildgaard N, \u00d8stergaard B, Schlemmer HP, Landgren O, Asmussen JT, Kaiser MF, Padhani A (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology 291(1):5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949","journal-title":"Radiology"},{"issue":"1","key":"1851_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","volume":"71","author":"AR Padhani","year":"2017","unstructured":"Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Schlemmer HP, Petralia G, Vargas HA, Fanti S, Tombal HB, de Bono J (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71(1):81\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.033","journal-title":"Eur Urol"},{"key":"1851_CR32","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978\u201394\u201392671\u201319\u20136. EAU Guidelines Office, Arnhem. https:\/\/uroweb.org\/guidelines\/prostate-cancer"},{"key":"1851_CR33","unstructured":"All-in-One Prostate Cancer Staging With MRI (AllinOne MRI). ClinicalTrials.gov ID: NCT06071195."},{"issue":"6","key":"1851_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.euo.2018.11.009","volume":"2","author":"J Morote","year":"2019","unstructured":"Morote J, Celma A, Roche S, de Torres IM, Mast R, Semedey ME, Regis L, Planas J (2019) Who benefits from multiparametric magnetic resonance imaging after suspicion of prostate cancer? Eur Urol Oncol 2(6):664\u2013669. https:\/\/doi.org\/10.1016\/j.euo.2018.11.009","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"1851_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eururo.2011.09.019","volume":"61","author":"G Giannarini","year":"2012","unstructured":"Giannarini G, Petralia G, Thoeny HC (2012) Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol 61(2):326\u2013340. https:\/\/doi.org\/10.1016\/j.eururo.2011.09.019","journal-title":"Eur Urol"},{"issue":"1A","key":"1851_CR36","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1102\/1470-7330.2010.9030","volume":"10","author":"G Petralia","year":"2010","unstructured":"Petralia G, Thoeny HC (2010) DW-MRI of the urogenital tract: applications in oncology. Cancer Imaging 10(1A):S112. https:\/\/doi.org\/10.1102\/1470-7330.2010.9030","journal-title":"Cancer Imaging"},{"issue":"2","key":"1851_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N (2014) European association of Urology EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65(2):467\u2013479. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.002","journal-title":"Eur Urol"},{"issue":"2","key":"1851_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"MS Cookson","year":"2007","unstructured":"Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D\u2019Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American urological association prostate guidelines for Localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177(2):540\u2013545. https:\/\/doi.org\/10.1016\/j.juro.2006.10.097","journal-title":"J Urol"},{"issue":"4","key":"1851_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965\u2013974. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1851_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-020-00315-0","volume":"20","author":"F Zugni","year":"2020","unstructured":"Zugni F, Padhani AR, Koh DM, Summers PE, Bellomi M, Petralia G (2020) Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations. Cancer Imaging 20(1):34. https:\/\/doi.org\/10.1186\/s40644-020-00315-0","journal-title":"Cancer Imaging"},{"issue":"3","key":"1851_CR41","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1148\/radiol.2021201740","volume":"299","author":"G Petralia","year":"2021","unstructured":"Petralia G, Koh DM, Attariwala R, Busch JJ, Eeles R, Karow D, Lo GG, Messiou C, Sala E, Vargas HA, Zugni F, Padhani AR (2021) Oncologically relevant findings reporting and data system (ONCO-RADS): guidelines for the acquisition, interpretation, and reporting of whole-body MRI for cancer screening. Radiology 299(3):494\u2013507. https:\/\/doi.org\/10.1148\/radiol.2021201740","journal-title":"Radiology"},{"issue":"12","key":"1851_CR42","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","volume":"20","author":"R Forstner","year":"2010","unstructured":"Forstner R, Sala E, Kinkel K, Spencer JA (2010) European society of urogenital radiology ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol 20(12):2773\u20132780. https:\/\/doi.org\/10.1007\/s00330-010-1886-4","journal-title":"Eur Radiol"},{"issue":"12","key":"1851_CR43","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","volume":"32","author":"A Gennari","year":"2021","unstructured":"Gennari A, Andr\u00e9 F, Barrios CH, Cort\u00e9s J, de Azambuja E, DeMichele A, Dent R, Fenlon D, Gligorov J, Hurvitz SA, Im SA, Krug D, Kunz WG, Loi S, Penault-Llorca F, Ricke J, Robson M, Rugo HS, Saura C, Schmid P, Singer CF, Spanic T, Tolaney SM, Turner NC, Curigliano G, Loibl S, Paluch-Shimon S, Harbeck N (2021) ESMO guidelines committee electronic address clinicalguidelines@esmo.org. ESMO Clinical Practice Guideline for the diagnosis staging and treatment of patients with metastatic breast cancer. Ann Oncol 32(12):1475\u20131495. https:\/\/doi.org\/10.1016\/j.annonc.2021.09.019","journal-title":"Ann Oncol"},{"issue":"3","key":"1851_CR44","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1148\/radiol.2020192683","volume":"297","author":"M Kosmin","year":"2020","unstructured":"Kosmin M, Padhani AR, Gogbashian A, Woolf D, Ah-See ML, Ostler P, Sutherland S, Miles D, Noble J, Koh DM, Marshall A, Dunn J, Makris A (2020) Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology 297(3):622\u2013629. https:\/\/doi.org\/10.1148\/radiol.2020192683","journal-title":"Radiology"},{"issue":"10","key":"1851_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205251","volume":"3","author":"F Zugni","year":"2018","unstructured":"Zugni F, Ruju F, Pricolo P, Alessi S, Iorfida M, Colleoni MA, Bellomi M, Petralia G (2018) The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer. PLoS ONE 3(10):e0205251. https:\/\/doi.org\/10.1371\/journal.pone.0205251","journal-title":"PLoS ONE"},{"issue":"2","key":"1851_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/uog.23654","volume":"59","author":"D Fischerova","year":"2022","unstructured":"Fischerova D, Pinto P, Burgetova A, Masek M, Slama J, Kocian R, Fr\u00fchauf F, Zikan M, Dusek L, Dundr P, Cibula D (2022) Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study). Ultrasound Obstet Gynecol 59(2):248\u2013262. https:\/\/doi.org\/10.1002\/uog.23654","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1851_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","volume":"83","author":"K Michielsen","year":"2017","unstructured":"Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V (2017) Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer 83:88\u201398. https:\/\/doi.org\/10.1016\/j.ejca.2017.06.010","journal-title":"Eur J Cancer"},{"key":"1851_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","volume":"114","author":"MP Engbersen","year":"2019","unstructured":"Engbersen MP, van Sant IT, Lok C, Lambregts DMJ, Sonke GS, Beets-Tan RGH, van Driel WJ, Lahaye MJ (2019) MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients. European J Radiol 114:146\u2013151. https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.007","journal-title":"European J Radiol"},{"key":"1851_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108696","volume":"121","author":"J Garcia Prado","year":"2019","unstructured":"Garcia Prado J, Gonz\u00e1lez Hernando C, Varillas Delgado D, Saiz Mart\u00ednez R, Bhosale P, Blazquez Sanchez J, Chiva L (2019) Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings. Eur J Radiol 121:108696. https:\/\/doi.org\/10.1016\/j.ejrad.2019.108696","journal-title":"Eur J Radiol"},{"key":"1851_CR50","unstructured":"The impact of multiparametric MRI on the staging and management of patients with suspected or confirmed ovarian cancer.2015 20\/11\/2018 Available from: http:\/\/www.isrctn.com\/ISRCTN51246892"},{"key":"1851_CR51","unstructured":"Clinical Impact of Dedicated MR Staging of Ovarian Cancer. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03399344"},{"issue":"3","key":"1851_CR52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejca.2005.10.008","volume":"42","author":"C M\u00fcller-Horvat","year":"2006","unstructured":"M\u00fcller-Horvat C, Radny P, Eigentler TK, Sch\u00e4fer J, Pfannenberg C, Horger M, Khorchidi S, N\u00e4gele T, Garbe C, Claussen CD, Schlemmer HP (2006) Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42(3):342\u2013350. https:\/\/doi.org\/10.1016\/j.ejca.2005.10.008","journal-title":"Eur J Cancer"},{"issue":"12","key":"1851_CR53","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1007\/s00330-013-2968-x","volume":"23","author":"G Petralia","year":"2013","unstructured":"Petralia G, Padhani A, Summers P, Alessi S, Raimondi S, Testori A, Bellomi M (2013) Whole-body diffusion-weighted imaging is it all we need for detecting metastases in melanoma patients? Eur Radiol 23(12):3466\u20133476","journal-title":"Eur Radiol"},{"issue":"2","key":"1851_CR54","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00330-022-09088-5","volume":"33","author":"AK Knill","year":"2023","unstructured":"Knill AK, Blackledge MD, Curcean A, Larkin J, Turajlic S, Riddell A, Koh DM, Messiou C, Winfield JM (2023) Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma. Eur Radiol 33(2):863\u2013871. https:\/\/doi.org\/10.1007\/s00330-022-09088-5","journal-title":"Eur Radiol"},{"issue":"3","key":"1851_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11547-018-0955-7","volume":"124","author":"G Petralia","year":"2019","unstructured":"Petralia G, Padhani AR, Pricolo P, Zugni F, Martinetti M, Summers PE, Grazioli L, Colagrande S, Giovagnoni A, Bellomi M (2019) Italian working group on magnetic resonance whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124(3):218\u2013233. https:\/\/doi.org\/10.1007\/s11547-018-0955-7","journal-title":"Radiol Med"},{"issue":"6","key":"1851_CR56","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2214\/AJR.17.18961","volume":"210","author":"MO Wielp\u00fctz","year":"2018","unstructured":"Wielp\u00fctz MO, Lee HY, Koyama H, Yoshikawa T, Seki S, Kishida Y, Sakai Y, Kauczor HU, Sugimura K, Ohno Y (2018) Morphologic characterization of pulmonary nodules with ultrashort TE MRI at 3T. AJR Am J Roentgenol 210(6):1216\u20131225. https:\/\/doi.org\/10.2214\/AJR.17.18961","journal-title":"AJR Am J Roentgenol"},{"key":"1851_CR57","doi-asserted-by":"publisher","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Hegde A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Patil T, Polanco PM, Riely GJ, Riess J, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hughes M (2023). NCCN Guidelines\u00ae Insights: Non-Small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 21(4):340\u2013350. https:\/\/doi.org\/10.6004\/jnccn.2023.0020.","DOI":"10.6004\/jnccn.2023.0020"},{"issue":"1","key":"1851_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, Seligmann J, De Baere T, Osterlund P, Yoshino T, Martinelli E (2023) ESMO guidelines committee. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"issue":"6","key":"1851_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1470-2045(22)00256-X","volume":"23","author":"J Davies","year":"2022","unstructured":"Davies J, Chew C, Bromham N, Hoskin P (2022) NICE 2020 guideline for the management of colorectal cancer. Lancet Oncol 23(6):247. https:\/\/doi.org\/10.1016\/S1470-2045(22)00256-X","journal-title":"Lancet Oncol"},{"issue":"7","key":"1851_CR60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S2468-1253(19)30056-1","volume":"4","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Beare S, Bhatnagar G, Blunt D, Boavida P, Bridgewater J, Clarke CS, Duggan M, Ellis S, Glynne-Jones R, Goh V, Groves AM, Hameeduddin A, Janes SM, Johnston EW, Koh DM, Miles A, Morris S, Morton A, Navani N, O\u2019Donohue J, Oliver A, Padhani AR, Pardoe H, Patel U, Punwani S, Quinn L, Rafiee H, Reczko K, Rockall AG, Shahabuddin K, Sidhu HS, Teague J, Thaha MA, Train M, van Ree K, Wijeyekoon S, Halligan S (2019) Streamline investigators diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective streamline C trial. Lancet Gastroenterol Hepatol. 4(7):529\u2013537. https:\/\/doi.org\/10.1016\/S2468-1253(19)30056-1","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"9","key":"1851_CR61","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1245\/s10434-020-08416-7","volume":"27","author":"MP Engbersen","year":"2020","unstructured":"Engbersen MP, Aalbers AGJ, Van\u2019t Sant-Jansen I, Velsing JDR, Lambregts DMJ, Beets-Tan RGH, Kok NFM, Lahaye MJ (2020) Extent of peritoneal metastases on preoperative DW-MRI is predictive of disease-free and overall survival for CRS\/HIPEC candidates with colorectal cancer. Ann Surg Oncol 27(9):3516\u20133524. https:\/\/doi.org\/10.1245\/s10434-020-08416-7","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1851_CR62","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ejso.2021.09.014","volume":"48","author":"I van Sant","year":"2022","unstructured":"van Sant I, Nerad E, Rijsemus CJV, Engbersen MP, Gispen CA, Lambregts DMJ, Beets-Tan RGH, Aalbers AGJ, Kok NFM, Lahaye MJ (2022) Seeing the whole picture: added value of MRI for extraperitoneal findings in CRS-HIPEC candidates. European J Surg Oncol 48(2):462\u2013546","journal-title":"European J Surg Oncol"},{"issue":"1","key":"1851_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jmri.24356","volume":"40","author":"TC Kwee","year":"2014","unstructured":"Kwee TC, Vermoolen MA, Akkerman EA, Kersten MJ, Fijnheer R, Ludwig I, Beek FJ, van Leeuwen MS, Bierings MB, Bruin MC, Zs\u00edros J, Quarles van Ufford HM, de Klerk JM, Adam J, Stoker J, Uiterwaal CS, Nievelstein RA (2014) Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study. J Magn Reson Imaging 40(1):26\u201336. https:\/\/doi.org\/10.1002\/jmri.24356","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"1851_CR64","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1007\/s00330-017-4907-8","volume":"27","author":"A Latifoltojar","year":"2017","unstructured":"Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A, D\u2019Sa S, Dikaios N, Sokolska M, Antonelli M, Ourselin S, Yong K, Taylor SA, Halligan S, Punwani S (2017) Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. Eur Radiol 27(12):5325\u20135336. https:\/\/doi.org\/10.1007\/s00330-017-4907-8","journal-title":"Eur Radiol"},{"issue":"11","key":"1851_CR65","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ejrad.2016.08.020","volume":"85","author":"V Ruhlmann","year":"2016","unstructured":"Ruhlmann V, Ruhlmann M, Bellendorf A, Grueneisen J, Sawicki LM, Grafe H, Forsting M, Bockisch A, Umutlu L (2016) Hybrid imaging for detection of carcinoma of unknown primary: a preliminary comparison trial of whole-body PET\/MRI versus PET\/CT. Eur J Radiol 85(11):1941\u20131947. https:\/\/doi.org\/10.1016\/j.ejrad.2016.08.020","journal-title":"Eur J Radiol"},{"issue":"3","key":"1851_CR66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ejrad.2010.02.013","volume":"79","author":"X Liang","year":"2011","unstructured":"Liang X, Congxin W, Yi Z, Jinwen H, Chuanfu L (2011) Whole-body diffusion-weighted MR imaging with fat suppression by using STIR: clinical utility for detection of primary malignancies in patients initially presented with metastasis. Eur J Radiol 79(3):359\u2013362. https:\/\/doi.org\/10.1016\/j.ejrad.2010.02.013","journal-title":"Eur J Radiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01851-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:13:09Z","timestamp":1725624789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":66,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1851"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01851-6","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors Andrea Giovagnoni and Vincenza Granata are editors in this journal. The remaining authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}